Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Neuroblastoma × XK 469 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 20 Vincristine 16 Carboplatin 14 Etoposide 11 Doxorubicin 11 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Radiotherapy 8 Melphalan 8 Isotretinoin 8 Filgrastim 8 Cisplatin 8 dinutuximab 7 X-Rays 7 Peripheral Blood Stem Cell Transplantation 7 Biopsy 7 aldesleukin 6 Temozolomide 6 Phantoms, Imaging 6 sargramostim 5 Topotecan 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Neoadjuvant Therapy 4 Irinotecan 4 Ipilimumab 4 Oxaliplatin 3 Granulocyte Colony-Stimulating Factor 3 Colony-Stimulating Factors 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡